Memantine

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial

This phase 2 trial demonstrates that memantine, an NMDA receptor antagonist, significantly reduces premature atrial contractions (PACs) and nonsustained atrial tachycardia burden, suggesting the cardiac glutamatergic system as a novel thera

Memantine Shows Promise for Improving Social Impairment in Youths with Autism Spectrum Disorder